$8.15
-0.20-2.4%
最終更新: Oct 23, 4:00 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 24
Benzinga
© 2026 Benzinga | All Rights Reserved
Immix Biopharma (IMMX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.17 | $-0.21 | $-0.16 | $-0.18 |
| Actual | $-0.18 | $-0.18 | $-0.28 | $-0.24 |
| Surprise | -5.88% | +14.3% | -75.0% | -33.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.18 | $-0.21 | $-0.22 | $-0.27 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.18 | $-0.17 | -5.88 % |
| Q1 | May 7, 2026 | $-0.18 | $-0.21 | 14.3 % |
| Q4 | Mar 25, 2026 | $-0.28 | $-0.16 | -75.0 % |
| Q3 | Nov 7, 2025 | $-0.24 | $-0.18 | -33.3 % |